本港证监会及港交所上周联合发函予新股保荐人，据报当中提到部分新上市申请质素欠佳，并关注某些不合规行为。事实上，近期新股市场阴睛不定，“B制新股必升”神话已然幻灭，虽然卓越睿新（2687）及宝济药业（2659）等继续有亮丽表现，但也不乏遇见小面（2408）及天域半导体（2658）等“破发”例子，其中目前正在招股的HASHKEY（3887）及果下科技（2655）也各有隐忧，投资者宜留意相关风险因素。据...
Source Link本港证监会及港交所上周联合发函予新股保荐人，据报当中提到部分新上市申请质素欠佳，并关注某些不合规行为。事实上，近期新股市场阴睛不定，“B制新股必升”神话已然幻灭，虽然卓越睿新（2687）及宝济药业（2659）等继续有亮丽表现，但也不乏遇见小面（2408）及天域半导体（2658）等“破发”例子，其中目前正在招股的HASHKEY（3887）及果下科技（2655）也各有隐忧，投资者宜留意相关风险因素。据...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.